AI evolves beyond mere algorithms to open up new frontiers in generative AI and agentic AI, and the art of the possible is ...

Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime editing-based pipeline focus to liver disease and programs funded by external ...

Regeneron to acquire nearly all of 23andMe’s assets for $256M, marking a new chapter for the direct-to-consumer genetic testing pioneer.

Artificial intelligence is changing the skills needed to succeed. A digitally-literate workforce is absolutely critical.

This is the first gene editor to use a CRISPR-associated transposase to make targeted edits at therapeutically useful levels in humans.

10x Genomics has settled patent infringement lawsuits with a pair of rivals, Bruker and Vizgen, through settlements that could reshape competition within the emerging single-cell and spatial genomics ...